Archive: 2025/11 - Page 3
The Ambrisentan Patent: Legal Issues Surrounding PAH Treatment
The ambrisentan patent battle delayed generic access to PAH treatment for years, driving up costs and limiting patient options. Learn how legal strategies impacted drug availability and why generics now offer affordable, effective care.
Read MoreRecent News
